4.5 Article

Ischaemic cardiac events and use of strontium ranelate in postmenopausal osteoporosis: a nested case-control study in the CPRD

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Efficacy and Safety of Strontium Ranelate in the Treatment of Osteoporosis in Men

J. -M. Kaufman et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Article Endocrinology & Metabolism

Bisphosphonates reduced the risk of acute myocardial infarction: a 2-year follow-up study

J. -H. Kang et al.

OSTEOPOROSIS INTERNATIONAL (2013)

Review Rheumatology

Osteoporosis-a risk factor for cardiovascular disease?

Christos E. Lampropoulos et al.

NATURE REVIEWS RHEUMATOLOGY (2012)

Article Pharmacology & Pharmacy

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

Emily Herrett et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)

Review Primary Health Care

Validity of diagnostic coding within the General Practice Research Database: a systematic review

Nada F. Khan et al.

BRITISH JOURNAL OF GENERAL PRACTICE (2010)

Article Public, Environmental & Occupational Health

Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database

Tarek A. Hammad et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)

Review Cardiac & Cardiovascular Systems

European guidelines on cardiovascular disease prevention in clinical practice: executive summary

Ian Graham et al.

EUROPEAN HEART JOURNAL (2007)

Article Medicine, General & Internal

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

PJ Meunier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)